Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 27;12(7):1433.
doi: 10.3390/biomedicines12071433.

Relationship between Serum Sirtuin 1 and Growth Hormone/Insulin-like Growth Factor 1 Concentrations in Children with Growth Hormone Deficiency and Idiopathic Short Stature

Anna Fedorczak  1 , Dorota Kowalik  1 , Justyna Kopciuch  2 , Ewa Głowacka  2 , Katarzyna Mikołajczyk  3   4 , Marcin Tkaczyk  3   4 , Andrzej Lewiński  1   5 , Renata Stawerska  1   5
Affiliations

Relationship between Serum Sirtuin 1 and Growth Hormone/Insulin-like Growth Factor 1 Concentrations in Children with Growth Hormone Deficiency and Idiopathic Short Stature

Anna Fedorczak et al. Biomedicines. .

Abstract

Sirtuin 1 (SIRT1) inhibits growth hormone (GH) intracellular signaling for the insulin-like growth factor 1 (IGF-1) synthesis via the janus kinase (JAK)/signal transducer and activator of transcription proteins (STATs) pathway. The aim of this study was to compare SIRT1 concentrations in children with GH deficiency (GHD) and so-called idiopathic short stature (ISS, non-GH deficient), in order to determine the possible impact of changes in serum SIRT1 concentrations on the GH-IGF-1 axis. The study group included 100 short-stature children: 38 with GHD and 62 with ISS (maxGH in two stimulation tests <10 and ≥10 ng/mL, respectively). The control group consisted of 47 healthy, normal-height children. For each child, the concentrations of SIRT1, IGF-1 and insulin-like growth factor-binding protein 3 (IGFBP-3) were determined and the IGF-1/IGFBP-3 molar ratio was calculated. The level of SIRT1 was significantly higher in both groups of short children than in the controls (p < 0.0001), but there were no differences between GHD and ISS (mean ± SD: 0.89 ± 0.45 for ISS; 1.24 ± 0, 86 for GHD; and 0.29 ± 0.21 for controls). A significant negative correlation was found between SIRT1 and height standard deviation score (SDS), IGF-1 and IGF-1/IGFBP-3, but not between SIRT1 and maxGH. Elevated SIRT1 levels may serve as one of the mechanisms through which the secretion of IGF-1 is reduced in children with short stature; however, further research is required to confirm this issue.

Keywords: IGF-1/IGFBP-3 molar ratio; JAK/STATs pathway; growth hormone; growth hormone deficiency; insulin-like growth factor 1; non-GH-deficient children; short stature; sirtuin 1.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Comparison of SIRT1 concentrations in short children with ISS (GH secretion ≥ 10 ng/mL) and GHD (GH secretion < 10 ng/mL) and in the control group.
Figure 2
Figure 2
Correlations between sirtuin 1 and height SDS, IGF-1 and IGF-1/IGFBP-3 molar ratio in whole analyzed group of children.
Figure 3
Figure 3
Correlations between serum SIRT1 concentration and body mass SDS, as well as serum SIRT1 and BMI SDS in analyzed group of short-stature children.
Figure 4
Figure 4
Comparison of SIRT1 levels in ISS (GH secretion ≥ 10 ng/mL), pGHD (GH secretion ≥ 7 and <10 ng/mL) and sGHD (GH secretion < 7 ng/mL) groups.
See this image and copyright information in PMC

References

    1. Juul A. Serum Levels of Insulin-like Growth Factor I and Its Binding Proteins in Health and Disease. Growth Horm. IGF Res. 2003;13:113–170. doi: 10.1016/S1096-6374(03)00038-8. - DOI - PubMed
    1. Boguszewski C.L., Barbosa E.J.L., Svensson P.A., Johannsson G., Glad C.A.M. Mechanisms in Endocrinology: Clinical and Pharmacogenetic Aspects of the Growth Hormone Receptor Polymorphism. Eur. J. Endocrinol. 2017;177:R309–R321. doi: 10.1530/EJE-17-0549. - DOI - PubMed
    1. Yakar S., Liu J.-L., Stannard B., Butler A., Accili D., Sauer B., LeRoith D. Normal Growth and Development in the Absence of Hepatic Insulin-like Growth Factor I. Proc. Natl. Acad. Sci. USA. 1999;96:7324–7329. doi: 10.1073/pnas.96.13.7324. - DOI - PMC - PubMed
    1. Juul A., Dalgaard P., Blum W.F., Bang P., Hall K., Michaelsen K.F., Müller J., Skakkebaek N.E. Serum Levels of Insulin-like Growth Factor (IGF)-Binding Protein-3 (IGFBP-3) in Healthy Infants, Children, and Adolescents: The Relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, Age, Sex, Body Mass Index, and Pubertal Maturation. J. Clin. Endocrinol. Metab. 1995;80:2534–2542. doi: 10.1210/jcem.80.8.7543116. - DOI - PubMed
    1. Rosenfeld R.G. Biochemical Diagnostic Strategies in the Evaluation of Short Stature: The Diagnosis of Insulin-like Growth Factor Deficiency. Horm. Res. 1996;46:170–173. doi: 10.1159/000185018. - DOI - PubMed

LinkOut - more resources